Trifarotene (Aklief)

Status:

Do Not Prescribe (DNP)

Decision Date:

September 2022

Comments

DNP: Cutaneous treatment of acne vulgaris of the face and/or the trunk in patients aged ≥12 years, when many comedones, papules and pustules are present.

Await clinician request to JAPC for a formal review.

search again